Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hancock

Showing results (461-470 of 476) with videos related to

Pageof 48
Sort By:
Scientific Reports|March 14, 2025
Author Correction: Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110αMohamed Ismail, Stephen R Martin, Roger George, et al.
BMJ Open|July 19, 2022
MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty - protocol for a double-blind, randomised controlled proof-of-concept trialKatherine J Rennie, Miles Witham, Penny Bradley, et al.
Scientific Reports|February 2, 2023
Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110αMohamed Ismail, Stephen R Martin, Roger George, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2011
Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2Jacob L Nankervis, Susanne C Feil, Nancy C Hancock, et al.
European Journal of Medicinal Chemistry|September 26, 2021
Development of [<sup>18</sup>F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory diseaseSiu Wai Wong, Lucy Vivash, Ramesh Mudududdla, et al.
Molecular Pharmaceutics|July 25, 2024
Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid)Maryam Sadat Sadeghi, Rui Guo, Michael A Bellucci, et al.
Neuro-Oncology|May 28, 2025
Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cellsMorgan J Coombs, Tyrone Dowdy, Md Masud Alam, et al.
Gynecologic Oncology|September 29, 2016
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancerJonathan Oh, Minal Barve, Carolyn M Matthews, et al.
Nature Cell Biology|October 27, 2014
ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1Yihua Wang, Fangfang Bu, Christophe Royer, et al.
BMJ Open|March 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acidSarah Dunn, Lysbeth Evans, Ciara Kennedy, et al.
Pageof 48

Showing results (461-470 of 476) with videos related to

Sort By:
Pageof 48
Scientific Reports|March 14, 2025
Author Correction: Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110αMohamed Ismail, Stephen R Martin, Roger George, et al.
BMJ Open|July 19, 2022
MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty - protocol for a double-blind, randomised controlled proof-of-concept trialKatherine J Rennie, Miles Witham, Penny Bradley, et al.
Scientific Reports|February 2, 2023
Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110αMohamed Ismail, Stephen R Martin, Roger George, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2011
Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2Jacob L Nankervis, Susanne C Feil, Nancy C Hancock, et al.
European Journal of Medicinal Chemistry|September 26, 2021
Development of [<sup>18</sup>F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory diseaseSiu Wai Wong, Lucy Vivash, Ramesh Mudududdla, et al.
Molecular Pharmaceutics|July 25, 2024
Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid)Maryam Sadat Sadeghi, Rui Guo, Michael A Bellucci, et al.
Neuro-Oncology|May 28, 2025
Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cellsMorgan J Coombs, Tyrone Dowdy, Md Masud Alam, et al.
Gynecologic Oncology|September 29, 2016
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancerJonathan Oh, Minal Barve, Carolyn M Matthews, et al.
Nature Cell Biology|October 27, 2014
ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1Yihua Wang, Fangfang Bu, Christophe Royer, et al.
BMJ Open|March 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acidSarah Dunn, Lysbeth Evans, Ciara Kennedy, et al.
Pageof 48